City
Epaper

AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials from tomorrow onwards: Sources

By ANI | Updated: June 14, 2021 14:25 IST

The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.

Open in App

The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.

According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine.

After the recruitment of 6-12 yr old children AIIMS Delhi will be conducting trials for the age group 2-6 yr old. The trails are taking place at 525 centres.

AIIMS Patna, Mysore Medical College and Reaserch Institute in Karnataka have also been selected to conduct clinical trials on children.

"We have started recruitment for children aged 6-12 years. Recruitments for clinical trails on children aged 12-18 years is over. They will be kept under observation." said Prabhat Kumar Singh, Director, AIIMS, Patna.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat Biotech InternationalMysore medical collegePrabhat Kumar SinghBharat biotech limitedBharat biotech international ltdBharat biotech company
Open in App

Related Stories

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

National"Digital health is very important now...": Bharat Biotech Executive Chairman Dr Krishna Ella at G20 Health Working Group Meet

NationalHyderabad: Union Minister Jitendra Singh inaugurates 'One Week One Lab' campaign at CSIR-IICT

NationalOn Republic Day, Bharat Biotech launches first India-made nasal Covid vaccine

HealthIndia's first ever nasal Covid vaccine iNCOVACC launched by Bharat Biotech

National Realted Stories

NationalTourists who return to Mumbai thank Centre, Maharashtra govt after Pahalgam terror attack

NationalPresident Droupadi Murmu to visit Vatican City for Pope Francis's funeral

NationalHelipad to be built at city bus terminal in Gurugram

NationalInfant dies after accidentally drinking chemical in Gurugram village

National'Terrorists behind Pahalgam massacre will not be spared', says Bengal BJP chief